詳細(xì)信息
- ;PR171關(guān)鍵中間體1;叔丁基-4-甲基-1-(2-甲基環(huán)氧乙烷-2-基)-1-氧代戊-2-基氨基甲酸;[(1S)-3-甲基-1-[[(2R)-2-甲基環(huán)氧乙基]羰基]丁基]氨基甲酸叔丁酯;((1S)-3-甲基-1-(((2R)-2-甲基環(huán)氧乙基)羰基)丁基)氨基甲酸叔丁酯;卡菲佐米中間體;卡菲佐咪中間體1;卡非佐米中間體;
- [(1S)-3-Methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]carbamic acid 1,1-dimethylethyl ester
- ;[3-Methyl-1-(2-methyl-oxiranecarbonyl)-butyl]-carbamic acid tert-butyl ester;tert-butyl (S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylcarbamate;Boc-Leucine-epoxylketone;tert-butyl 4-methyl-1-(2-methyloxiran-2-yl)-1-oxopentan-2-ylcarbamate;(2R)-2-[(2S)-2-(tert-Butoxycarbonylamino)-4-methylpentanoyl]-2-methyloxirane;Boc-L-leucine epoxyketone;((1s)-3-methyl-1-(((2r)-2-methyloxiranyl)carbonyl)butyl)carbamic acid 1,1-dimethylethyl ester;Carfilzomib intermediate 1;Tert-butyl N-[(2s)-4-methyl-1-[(2r)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamate;
免責(zé)聲明:以上所展示的信息由企業(yè)自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé),化工網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。我們?cè)瓌t上建議您選擇化工網(wǎng)高級(jí)會(huì)員或VIP會(huì)員。

![[(1S)-3-甲基-1-[[(2R)-2-甲基環(huán)氧乙基]羰基]丁基]氨基甲酸叔丁酯](https://images-a.chemnet.com/suppliers/chembase/779/2018779_1.png)